The Gross Margin of Myungmoon Pharm Co Ltd (017180.KS) is 56.30%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 56.30% |
2023-12-31 | 56.23% |
2022-12-31 | 51.34% |
2021-12-31 | 43.06% |
2020-12-31 | 38.32% |
2019-12-31 | 45.82% |
2018-12-31 | 50.48% |
2017-12-31 | 56.52% |
2016-12-31 | 53.58% |
2015-12-31 | 50.10% |